GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells

(2018) Julia Drube et al.   Oncotarget

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment

(2017) Marcella Tazzari et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

(2016) Daniel J Klionsky et al.   Autophagy

ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells

(2016) Maria Karvela et al.   Autophagy

Grancalcin (GCA) modulates Toll-like receptor 9 (TLR9) mediated signaling through its direct interaction with TLR9

(2016) Tae Whan Kim et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover of ULK1 and VPS34 Complexes to Control Autophagy Termination

(2016) Chin-Chih Liu et al.   MOLECULAR CELL

miRNA studies inin vitroandin vivoactivated hepatic stellate cells

(2016) Gunter Maubach   WORLD JOURNAL OF GASTROENTEROLOGY

Chaperone-like protein p32 regulates ULK1 stability and autophagy

(2015) H Jiao et al.   CELL DEATH AND DIFFERENTIATION

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

(2014) Daniel J. Klionsky et al.   Autophagy

You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia

(2014) A R Sehgal et al.   LEUKEMIA

A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia

(2014) L. Ma et al.   Science Translational Medicine

mTOR, AMBRA1, and autophagy: An intricate relationship

(2013) Francesca Nazio et al.   CELL CYCLE

Tyrosine kinase inhibition: a therapeutic target for the management of chronic-phase chronic myeloid leukemia

(2013) Elias J Jabbour et al.   Expert Review of Anticancer Therapy

mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6

(2013) Francesca Nazio et al.   NATURE CELL BIOLOGY

Insulin-Stimulated Degradation of Apolipoprotein B100: Roles of Class II Phosphatidylinositol-3-Kinase and Autophagy

(2013) Ursula Andreo et al.   PLoS One

BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription

(2011) Z. Sheng et al.   BLOOD

Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML

(2011) G. V. Helgason et al.   BLOOD

Development of an Effective Therapy for Chronic Myelogenous Leukemia

(2011) David W. Woessner et al.   CANCER JOURNAL

Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

(2011) Magnus Björkholm et al.   JOURNAL OF CLINICAL ONCOLOGY

Hsp90-Cdc37 Chaperone Complex Regulates Ulk1- and Atg13-Mediated Mitophagy

(2011) Joung Hyuck Joo et al.   MOLECULAR CELL

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

(2011) Joungmok Kim et al.   NATURE CELL BIOLOGY

Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib

(2011) T-M Kim et al.   Blood Cancer Journal

HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy

(2010) Joo-Yong Lee et al.   EMBO JOURNAL

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

(2010) S. Flamant et al.   HAEMATOLOGICA

Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia

(2010) D Bixby et al.   LEUKEMIA

Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies

(2010) Armin Wolf et al.   LEUKEMIA RESEARCH

Targeted therapies and autophagy: new insights from chronic myeloid leukemia

(2009) Paolo Salomoni et al.   Autophagy

Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent

(2009) Soo-Hyun Kim et al.   HEMATOLOGICAL ONCOLOGY

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

(2009) Cristian Bellodi et al.   JOURNAL OF CLINICAL INVESTIGATION

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

(2009) Michele Baccarani et al.   JOURNAL OF CLINICAL ONCOLOGY

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

(2009) A Hochhaus et al.   LEUKEMIA

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

(2009) Edurne San José-Enériz et al.   Molecular Cancer